Scholar IQ
Try ScholarIQ free
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Heart rate and cardiovascular health

TopicLeading institutions, researchers & key papers

Heart rate and cardiovascular health is a topic indexed in ScholarIQ from OpenAlex.

What is known about Heart rate and cardiovascular health?

ScholarIQrecord summary

This cluster of papers explores the impact of resting heart rate on cardiovascular health, focusing on its association with various conditions such as coronary artery disease, heart failure, hypertension, and diabetes mellitus. The papers also investigate the use of Ivabradine, a selective If inhibitor, in managing stable angina and chronic heart failure by reducing heart rate. Additionally, they highlight the predictive value of resting heart rate for mortality and its role as a risk factor for cardiovascular diseases.

How many works does Heart rate and cardiovascular health have?

ScholarIQindexed works

Heart rate and cardiovascular health has 67 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Heart rate and cardiovascular health?

ScholarIQopenalex

The OpenAlex for Heart rate and cardiovascular health is on the source record.

What are the most-cited papers on Heart rate and cardiovascular health?

ScholarIQmost cited works
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi
The Lancet. 20102,563 CitationsOPEN ACCESS
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies
Dagfinn Aune, Edward L. Giovannucci, Paolo Boffetta, Lars Thore Fadnes, NaNa Keum, Teresa Norat, Darren C. Greenwood, Elio Ríboli, Lars J. Vatten, Serena Tonstad
International Journal of Epidemiology. 20162,455 CitationsOPEN ACCESS
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life
Dipak Kotecha, Karina V Bunting, Simrat Gill, Samir Mehta, Mary Stanbury, J. C. H. Jones, Sandra Haynes, Melanie Calvert, Jonathan J Deeks, Richard P. Steeds, Victoria Y. Strauss, Kazem Rahimi, A. John Camm, Michael Griffith, Gregory Y.H. Lip, John Townend, Paulus Kirchhof, Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) Team
JAMA. 2020232 CitationsOPEN ACCESS
Real-world heart rate norms in the Health eHeart study
Robert Avram, Geoffrey H. Tison, Kirstin Aschbacher, Peter Kuhar, Eric Vittinghoff, Michael Butzner, Ryan Runge, Nancy Wu, Mark J. Pletcher, Gregory M. Marcus, Jeffrey E. Olgin
npj Digital Medicine. 2019209 CitationsOPEN ACCESS
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)
Maurizio Volterrani, Gennaro Cice, Giuseppe Caminiti, Cristiana Vitale, Salvatore D’Isa, Pasquale Perrone Filardi, Flavio Acquistapace, Giuseppe Marazzi, Massimo Fini, Giuseppe Rosano
International Journal of Cardiology. 2011128 Citations

Where is Heart rate and cardiovascular health research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Heart rate and cardiovascular health is open access?

ScholarIQopen access share
77%OPEN ACCESS
Gold
46%
Green
8%
Hybrid
0%
Bronze
23%
Closed
23%

Related on ScholarIQ

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Paper
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Paper
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Paper
Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose-response meta-analysis of prospective studies
Paper
Status of Hypertension in China
Paper
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Paper
470M+ articles · 14-day free trial